Inverness Counsel’s Bio-Techne TECH Stock Holding History

Inverness Counsel’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,664	Closed	-$215K	–	202
2021 Q4	$215K	Buy	+1,664	New	+$204K	0.01%	181

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Inverness Counsel's TECH Position: Q1 2022 in Review

Inverness Counsel sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 1,664 shares — an estimated $215K sold.

Inverness Counsel first reported a position in TECH in Q4 2021 and held it in 1 quarter. The position peaked at $215K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

Inverness Counsel reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
Inverness Counsel sold 1,664 Bio-Techne shares in Q1 2022, an estimated $215K.
Inverness Counsel first reported a position in Bio-Techne in Q4 2021 and held it in 1 quarter.
Inverness Counsel's Bio-Techne position peaked at $215K in Q4 2021.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Inverness Counsel's 13F filing for Q1 2022, filed 5 May 2022.